Board 2018-01-03T21:54:54+00:00

Greg Share, Chairman of the Board, PeriGen

Greg Share – Chairman.

Greg Share is President of Ambina Partners, a private investment firm focused on investing in financial services and software companies.  Mr. Share has over twenty years of private equity experience and previously led software and financial services investing at Moelis Capital Partners, a mid-market private equity fund where he was a Partner and Investment Committee Member from 2008 until 2015. Prior to joining Moelis, Mr. Share served as a Managing Director of Fortress Investment Group from 2003 to 2008.  Before joining Fortress, Mr. Share was a Vice President at Madison Dearborn Partners and started his investment career at Lazard Freres.

Mr. Share currently holds Board Member roles with several privately-held companies in addition to PeriGen, Inc.  They include Princeton Hosted Solutions (Telecom), Veritas Financial Partners (Specialty Finance), and Washify (Retail SAAS Software).

Previously, Mr. Share served as Chairman of Kinsale Capital Group (NASDAQ: KNSL), a specialty insurer, and as a board member with EPIQ Systems (NASDAQ: EPIQ), a leading provider of e-discovery solutions, as well as several privately-held businesses including Insurance Technologies (Insurance Software), Mxi Technologies (ERP Software), OneTitle National Guaranty Company (Title Insurer), and SwipeClock (HR Software).


John Gomez, CEO, Sensato

John Gomez – Director.

John Gomez is the Chief Executive Officer of Sensato, a company providing cyber-security, privacy and compliance assessments to healthcare information technology organizations and vendors.  During is career he has run both small and large organization in roles involving R&D, product strategy, planning, consulting, product support, sales and marketing.  His industry experience includes healthcare, telecom, media, federal, security, energy, and consumer markets.

Mr. Gomez has been described as a very hands-leader who focuses on achieving long-term, sustainable growth driven by short-term achievements.  He believes clear goals, vision, and objectives are essential for success.

His key achievements included being called “the Steve Jobs of Healthcare” by HISTALK, the leading HIT blog in North America, being selected as one of the top-100 Hispanic IT leaders, and developing a profitable international business unit from $0 to more than $100 million in 36 months that was breakeven from year one.

Mr. Gomez has held leadership positions at JGo Labs, Group Espada, Allscripts, WebMD, Brill Media, and Contentville.


Sachin Sarnobat – Director.

Sachin Sarnobat is a Managing Director of Atalaya Capital Management.  Prior to joining Atalaya, Mr. Sarnobat worked with Prospect Capital Management, a multi-billion dollar credit and private equity fund, where he served on the investment committee, headed the illiquid public debt strategy, and structured private investments in esoteric assets. Prior to Prospect Capital Management, Mr. Sarnobat also worked in the investment banking practices of Citigroup and Merrill Lynch, where he originated and executed mergers, acquisitions, debt and equity transactions for a variety of private equity and corporate clients. Mr. Sarnobat began his career at a technology start-up that provided advanced analytics to the consumer credit risk industry and was awarded a U.S. patent related to data mining. Mr. Sarnobat earned his BS in Chemical Engineering from the University of Mumbai and his MBA with honors from Columbia University Business School. Mr. Sarnobat also earned his Masters in Chemical Engineering from the University of Tennessee Knoxville, based on his research on Chaos Theory at Oak Ridge National Laboratory.


David. W. Jahns – Director.

Mr. Jahns is a Managing Director of Galen Partners, a leading healthcare growth equity investment firm founded in 1990.  With experience in over 70 growth equity investments, Mr. Jahns has developed substantial expertise and leadership in working with entrepreneurs to build market-leading healthcare companies in the areas of medical devices and technology-enabled services.  Prior to joining Galen in 1993, Mr. Jahns was an investment banker and financial advisor to healthcare companies.  He worked in the Corporate Finance Department at Smith Barney, Inc. in New York, specializing in public offerings and mergers and acquisitions, as well as public debt financings.  As an investment banker and venture capitalist, Mr. Jahns has worked on more than 20 initial public offerings, including 11 Galen portfolio companies’ IPOs.  Additionally, he has extensive M&A experience including 19 portfolio companies’ sales to financial and strategic buyers.

Mr. Jahns has served on numerous public company Boards of Directors and currently serves several Galen portfolio companies including: CBL Pathology, Dakim Brain Fitness, Unisyn Medical Technologies, PeriGen, InTouch Health, and USHIFU.

Mr. Jahns earned an MBA from the Northwestern University, Kellogg School of Management, where he specialized in Health Services Management and is currently a guest lecturer on private equity and venture capital case studies.  He earned his BA in political science and economics from Colgate University, where he graduated Phi Beta Kappa.